Thomas McCourt
Chief Executive Officer presso IRONWOOD PHARMACEUTICALS, INC.
Patrimonio netto: 11 M $ in data 31/03/2024
Profilo
Thomas A.
McCourt is the founder of Astra Merck, Inc., which was founded in 1992.
He held the title of Manager-Prilosec & Nexium Brand from 1992 to 1999.
Mr. McCourt's current job(s) include being the President, Chief Executive Officer & Director at Ironwood Pharmaceuticals, Inc. since 2009, an Independent Director at Pliant Therapeutics, Inc. since 2023, and a Trustee at the American Society for Gastrointestinal Endoscopy since 2009.
Mr. McCourt's former job(s) include being an Independent Director at Acceleron Pharma, Inc. from 2016 to 2021, and Vice President-Strategic Marketing & Operations at Novartis AG from 2001 to 2008.
Mr. McCourt's education history includes completing his undergraduate degree at the University of Wisconsin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 08/03/2024 | 1 217 948 ( 0.78% ) | 11 M $ | 31/03/2024 | |
| 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Thomas McCourt
| Società | Posizione | Inizio |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Chief Executive Officer | 12/03/2021 |
| PLIANT THERAPEUTICS, INC. | Director/Board Member | 06/03/2023 |
| American Society for Gastrointestinal Endoscopy | Director/Board Member | 01/05/2009 |
Precedenti posizioni note di Thomas McCourt
| Società | Posizione | Fine |
|---|---|---|
| ACCELERON PHARMA INC. | Director/Board Member | 19/11/2021 |
| NOVARTIS AG | Sales & Marketing | 01/01/2008 |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Founder | 01/06/1999 |
Formazione di Thomas McCourt
| University of Wisconsin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
| American Society for Gastrointestinal Endoscopy |
- Borsa valori
- Insiders
- Thomas McCourt
